Saltar al contenido
Merck

[Immunomodulation with fumaric acid. Systemic therapy in psoriasis].

Orvosi hetilap (2000-02-29)
B Sebók, I Schneider
RESUMEN

The treatment of psoriasis vulgaris with fumaric acid esters has been controversial for more than 30 years. Recently the fumaric acid derivatives are marketed antipsoriatics in many European countries. In this paper the clinical efficacy, the side effects as well as the mode of action of these highly potent substances are summarized.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Fumaric acid, ≥99.0% (T)
Sigma-Aldrich
Fumaric acid, FCC, FG
Supelco
Fumaric Acid, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Fumaric acid, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Fumaric acid, European Pharmacopoeia (EP) Reference Standard